{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:55:33Z","timestamp":1778799333992,"version":"3.51.4"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144562","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T07:39:11Z","timestamp":1449646751000},"page":"e0144562","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Clinical Characteristics of 582 Patients with Uveal Melanoma in China"],"prefix":"10.1371","volume":"10","author":[{"given":"Yue Ming","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Bin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jost B.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"AD Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","article-title":"Incidence of uveal melanoma in Europe","volume":"114","author":"G Virgili","year":"2007","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/PAP.0000000000000010","article-title":"Uveal melanoma: A pathologist\u2019s perspective and review of translational developments","volume":"21","author":"L Schoenfield","year":"2014","journal-title":"Advances in anatomic pathology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcjo.2012.03.038","article-title":"Uveal melanoma prognostication: from lesion size and cell type to molecular class","volume":"47","author":"HS Gill","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"ref5","article-title":"Group: COMS Manual of Procedures, PB95-179693","year":"1995"},{"key":"ref6","first-page":"433","article-title":"Uveal melanoma: clinical characteristics, treatment and survival in a series of 500 patients","volume":"88","author":"N Vicente","year":"2013","journal-title":"Arch SocEspOftalmol"},{"key":"ref7","first-page":"280","article-title":"Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis","volume":"11","author":"S Frenkel","year":"2009","journal-title":"Israel Med Assoc J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0161-6420(03)00077-0","article-title":"Survival rates with uveal melanoma in the United States: 1973\u20131997","volume":"110","author":"AD Singh","year":"2003","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archopht.126.10.1413","article-title":"Survival in patients with uveal melanoma in Europe","volume":"126","author":"G Virgili","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"ref10","first-page":"3","article-title":"Survival from uveal melanoma in England and Wales 1986 to 2001","volume":"14","author":"JM Burr","year":"2007","journal-title":"OphthalEpidemiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1167\/iovs.03-0081","article-title":"Uveal melanoma survival in Sweden from 1960 to 1998","volume":"44","author":"L Bergman","year":"2003","journal-title":"Invest Ophthal Visual Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/eye.2015.51","article-title":"Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture","volume":"29","author":"CL Shields","year":"2015","journal-title":"Eye (Lond)"},{"key":"ref13","first-page":"41","article-title":"Clinical and histopathological characteristics of uveal melanoma in Asian Indians. A study of 103 patients","volume":"52","author":"J Biswas","year":"2004","journal-title":"Indian J Ophthalmol"},{"key":"ref14","first-page":"343","article-title":"Age distribution of uveal melanoma and its relationship to survival","volume":"82","author":"X Graell","year":"2007","journal-title":"Arch Soc Esp"},{"key":"ref15","first-page":"403","article-title":"Uveal melanomas in children and adolescents","volume":"2","author":"L Apt","year":"1962","journal-title":"IntOphthalmolClin"},{"key":"ref16","first-page":"387","article-title":"Prognosis of malignant melanomas of the choroid and ciliary body","volume":"2","author":"EV Paul","year":"1962","journal-title":"IntOphthalmolClin"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1001\/archopht.1981.03930021009003","article-title":"Uveal melanoma in children and adolescents","volume":"99","author":"CC Barr","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s00417-006-0347-x","article-title":"Uveal melanoma in young patients","volume":"244","author":"A Pogrzebielski","year":"2006","journal-title":"Graefes Arch ClinExpOphthalmol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"CL Shields","year":"2012","journal-title":"Retina"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5301\/ejo.5000200","article-title":"Influence of age on prognosis of young patients with uveal melanoma: A matched retrospective cohort study","volume":"23","author":"S Kaliki","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1167\/iovs.12-10365","article-title":"Gender differences in clinical presentation and prognosis of uveal melanoma","volume":"54","author":"O Zloto","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1200\/JCO.2005.02.6534","article-title":"Variates of survival in metastatic uveal melanoma","volume":"23","author":"P Rietschel","year":"2005","journal-title":"J ClinOncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve\u2011year mortality rates and prognostic factors: COMS report No 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0002-9394(98)00039-7","article-title":"The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre\u2011enucleation radiation of large choroidal melanoma II: Initial mortality findings. COMS report no 10","volume":"125","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ajo.2004.07.006","article-title":"The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre\u2011enucleation radiation of large choroidal melanoma: IV. Ten\u2011year mortality findings and prognostic factors. COMS report number 24","volume":"138","author":"BS Hawkins","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter\u2011by\u2011millimeter in 8033 consecutive eyes","volume":"127","author":"CL Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long\u2011term prognosis of patients with malignant uveal melanoma","volume":"44","author":"E Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0046-8177(82)80116-0","article-title":"Uveal melanoma: Location, size, cell type, and enucleation as risk factors in metastasis","volume":"13","author":"IW McLean","year":"1982","journal-title":"Hum Pathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ophtha.2008.04.025","article-title":"Routes of extraocular extension of uveal melanoma: Risk factors and influence on survival probability","volume":"115","author":"SE Coupland","year":"2008","journal-title":"Ophthalmology"},{"key":"ref30","first-page":"131","article-title":"Malignant melanotic tumors of the eye. A study of histologic types in 111 cases","volume":"36","author":"GR Callender","year":"1931","journal-title":"Trans Am AcadOphthalmolOtolaryngol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9394(14)77914-0","article-title":"Modifications of Callender\u2019s classification of uveal melanoma at the Armed Forces Institute of Pathology","volume":"96","author":"IW McLean","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"ref32","first-page":"387","article-title":"Prognosis of malignant melanomas of the choroid and ciliary body","volume":"2","author":"EV Paul","year":"1962","journal-title":"IntOphthalmolClin"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archopht.1987.01060060087039","article-title":"Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors","volume":"105","author":"JM Seddon","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","article-title":"Cytogenetics of uveal melanoma: a 7-year clinical experience","volume":"114","author":"B Damato","journal-title":"Ophthalmology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ophtha.2010.05.023","article-title":"Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens","volume":"118","author":"CL Shields","year":"2011","journal-title":"Ophthalmology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ajpath.2012.11.036","article-title":"Single nucleotide polymorphism array analysis of uveal melanomas reveals that amplification of CNKSR3 is correlated with improved patient survival","volume":"182","author":"SL Lake","year":"2013","journal-title":"Am J Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1167\/iovs.14-14550","article-title":"Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma","volume":"55","author":"KG Ewens","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ijc.23664","article-title":"Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy","volume":"123","author":"AA Brozyna","year":"2008","journal-title":"Int J Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ijc.24005","article-title":"Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells","volume":"124","author":"A Slominski","year":"2009","journal-title":"Int J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma","volume":"44","author":"AA Bro\u017cyna","year":"2013","journal-title":"Hum Pathol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T12:47:41Z","timestamp":1540039661000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144562"}},"subtitle":[],"editor":[{"given":"Andrzej T","family":"Slominski","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,8]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144562","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,8]]}}}